 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval& `- L# b2 g, \7 z5 ~9 J
% O; V. R, L" l( f" \4 `6 J! |# LEDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX." B9 E% s2 \7 o* z4 z% g) i
$ D; B/ f! V# b2 s) J
BY THE EDMONTON JOURNAL FEBRUARY 16, 2007; R* {: o+ H% q- X# K* J
5 J L: M a P! z) V; P
. W0 h. ^* a" I, Y& A& q
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
$ g( F! i9 S' R+ m1 f6 ]- {3 M7 y$ [4 }4 }1 i7 n
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM." i/ s6 g1 G2 X1 R# l/ d. |
. i' h1 t% L6 Y: S- ^
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.3 o' K2 y8 G7 p# W) L2 U
" o/ X2 f- Q4 Z2 k# }% L9 HIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
' G5 K' M4 l* c4 k
3 c; ?+ N R8 m1 ~/ wIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million. u$ M& y7 V2 a! x& @6 ]! E" E& R
! k, g U- n" t0 F! n"As a scientist, it's one of the highlights of my CAREER," Shan said.
+ u9 `/ f, l0 b, p1 `8 E
: {' x) m) M6 p% v6 w"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
" R+ V) {/ S4 G+ C/ l' \$ D, k: M1 I" \
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.7 G( f! _. A1 U% L6 p: s
5 s, j q" K6 x) lGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
1 @( Y, v% r6 D5 `; P$ r" e5 R+ z. E/ s" v2 F0 N0 m5 c
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
3 c+ @8 z. n. t$ Y4 [" {
; G2 G1 _6 A1 x5 D
9 i ?% I& m! vhttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
' b" m! a/ E6 L, P) b/ _6 G
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
发表于 2015-2-28 19:45
